KMB
Kimberly-ClarkDInvestment thesisAs of 2026-11-03
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-11-03. Definitions
Kimberly-Clark’s Oct. 15 preliminary Q3 release had already disclosed estimated adjusted EPS of $1.70 and net sales of $4.134B, substantially pre-empting any fresh Q3 earnings-surprise thesis; it also reported negative organic sales and reaffirmed its prior full-year outlook. Shares then fell sharply on Nov. 3 on unusually high volume and closed near the low.
Confirming evidence
- • 1 setup hits (3d) with net bullish as of 2026-11-03.
- • News driver: Kimberly-Clark Offers Bonds to Help Fund Tylenol Maker Takeover.
- • Next scheduled catalyst: earnings 2026-11-05 · BMO.
Contradictions & invalidation
- • China diaper-sales disruption may persist beyond management's near-term expectations. [#SEC-8K-2026-08-04]
- • Reported margin improvement included one-time tariff refunds; pricing investments and supply-chain spending may limit repeatability. [#SEC-8K-2026-08-04]
- • Q2 organic sales were slightly negative, while China disruption, price investments and business exits weighed on performance.
Catalyst clock
2026-11-05 · BMO
President and COO departure
Composite grade D. Momentum 57.8 / Value 47.1 / Sentiment 45.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-02. Scenario method

